Science & Research Staff Directory
CAMH is a leader in mental health research, with more than 120 scientists at the core of our research enterprise.
Meet Our Scientists
Dr. Tyler Kaster
Scientist, Temerty Centre for Therapeutic Brain Intervention
Tyler.kaster@camh.ca About Dr. Tyler Kaster
Dr. James L. Kennedy
Scientific Director, Tanenbaum Centre for Pharmacogenetics
jim.kennedy@camh.ca About Dr. James L. Kennedy
Dr. Michael Kiang
Senior Scientist, Slaight Family Centre for Youth in Transition
michael.kiang@camh.ca About Dr. Michael Kiang
Dr. Sean A. Kidd
Senior Scientist, Slaight Family Centre for Youth in Transition
sean.kidd@camh.ca About Dr. Sean A. Kidd
Dr. Robert Kleinman
Scientist, Institute for Mental Health Policy Research
robert.kleinman@camh.ca About Dr. Robert Kleinman
Dr. Stefan Kloiber
Senior Scientist, General Adult Psychiatry and Health Systems Division
stefan.kloiber@camh.ca About Dr. Stefan Kloiber
Dr. Nicole Kozloff
Scientist and Co-Director, Slaight Family Centre for Youth in Transition
nicole.kozloff@camh.ca About Dr. Nicole Kozloff
Dr. Sanjeev Kumar
Scientist, Adult Neurodevelopment and Geriatric Psychiatry Division
sanjeev.kumar@camh.ca About Dr. Sanjeev KumarDr. Paul Kurdyak
Senior Scientist, Institute for Mental Health Policy Research, and General Adult Psychiatry and Health Systems Division
paul.kurdyak@camh.ca About Dr. Paul Kurdyak
Dr. Meng-Chuan Lai
Senior Scientist, McCain Centre for Child, Youth and Family Mental Health and Azrieli Adult Neurodevelopmental Centre
meng-chuan.lai@camh.ca About Dr. Meng-Chuan Lai
ASCME Trial: Major National Study Aims to Advance Treatment for Methamphetamine Use Disorder
CAMH leads Ontario arm of largest clinical trial ever to help close the treatment gap
Read More
SUMMIT Trial News Release
New study reveals promising strategies to provide the necessary support and treatment more effectively and inclusively for pregnant and postpartum populations.
Read More
New CAMH-Developed Drug Shows Promise in Reversing Memory Loss for Early Alzheimer's Patients
Pre-clinical trial suggests treatment may slow the progression of Alzheimer’s and restore cognitive function.
Read More